Belladonna Alkaloids with Phenobarbital

Product NDC
0143-1140
11-digit product format
001431140
Labeler code
0143
Product ID
0143-1140_88a8ad45-3957-45b0-ae70-d0a11ba0aef9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Belladonna Alkaloids with Phenobarbital
Dosage form
TABLET
Route
ORAL
Labeler
West-Ward Pharmaceuticals Corp
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
1966-01-01
Marketing end
0000-00-00
Substance
HYOSCYAMINE SULFATE; ATROPINE SULFATE; SCOPOLAMINE HYDROBROMIDE; PHENOBARBITAL
Active strength
0 mg/1; mg/1; mg/1; mg/1
Pharmacologic classes
Anticholinergic [EPC],Cholinergic Antagonists [MoA],Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA],Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0143-1140DDiscontinued by firm2026-10-05
excluded packagepackage0143-11400143-1140-01DDiscontinued by firm2026-10-05
excluded packagepackage0143-11400143-1140-10DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0143-1140-10d630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage0143-1140-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0143-1140-10f5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage0143-1140-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0143-1140-102ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage0143-1140-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0143-1140-10a1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage0143-1140-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0143-1140-10cfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage0143-1140-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0143-1140-10cdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage0143-1140-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0143-1140-10302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage0143-1140-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0143-1140-10ed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage0143-1140-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0143-1140-100efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage0143-1140-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0143-1140-10ad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage0143-1140-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0143-1140-10367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage0143-1140-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0143-1140-10557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage0143-1140-01557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c78bd43-efb4-4aeb-b7d8-eff1532f7822Product name420250801
41231c1e-8789-4da7-ac52-77fa90a85bf5Product name220250304
fe8ea78e-e1a4-44bf-a6b2-42eed76976bbProduct name520250218
e77ab9a2-80cf-4832-bff0-469bbc7cbcd0Product name220250214
5f84b7a7-523a-f042-dffb-1dadcd9b2407Product name420240110
e3e67a66-d325-4d80-8f9d-059e736d7b00Product name120230912
0cbc6fb2-78c0-4b88-98f0-a4cc76ff95caProduct name120230719
04cd5dc0-102f-46cb-8dbc-ca38dd2628d0Product name320230317
dfd25202-b8d2-4628-9213-f3e0f9eafce5Product name420210513
4199bf9b-4718-828a-6dd6-ac2fbbd61687Product name120140508
4edd8af5-cea7-ae42-8023-e91c5335db1dProduct name120140508
d3908afb-7784-440f-c406-88294732d36aProduct name120140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0143-1140-01EA - Each0143-11404483f96a-3775-41d0-a65e-a20a736d320412017-08-11
0143-1140-10EA - Each0143-1140bca9477c-895f-429f-a393-427166451a7612017-07-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ATROPINE SULFATEACTIVE INGREDIENT03J5ZE7KA5BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
ATROPINE SULFATEACTIVE INGREDIENT03J5ZE7KA5BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
ATROPINE SULFATEACTIVE INGREDIENT03J5ZE7KA5BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
HYOSCYAMINE SULFATEACTIVE INGREDIENTF2R8V82B84BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
HYOSCYAMINE SULFATEACTIVE INGREDIENTF2R8V82B84BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
HYOSCYAMINE SULFATEACTIVE INGREDIENTF2R8V82B84BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
PHENOBARBITALACTIVE INGREDIENTYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
SCOPOLAMINE HYDROBROMIDEACTIVE INGREDIENT451IFR0GXBBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
SCOPOLAMINE HYDROBROMIDEACTIVE INGREDIENT451IFR0GXBBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
SCOPOLAMINE HYDROBROMIDEACTIVE INGREDIENT451IFR0GXBBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
ATROPINEACTIVE MOIETY7C0697DR9IBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
ATROPINEACTIVE MOIETY7C0697DR9IBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
ATROPINEACTIVE MOIETY7C0697DR9IBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
HYOSCYAMINEACTIVE MOIETYPX44XO846XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
HYOSCYAMINEACTIVE MOIETYPX44XO846XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
HYOSCYAMINEACTIVE MOIETYPX44XO846XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
PHENOBARBITALACTIVE MOIETYYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
PHENOBARBITALACTIVE MOIETYYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
PHENOBARBITALACTIVE MOIETYYQE403BP4DBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
SCOPOLAMINEACTIVE MOIETYDL48G20X8XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
SCOPOLAMINEACTIVE MOIETYDL48G20X8XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
SCOPOLAMINEACTIVE MOIETYDL48G20X8XBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
CALCIUM STEARATEINACTIVE INGREDIENT776XM7047LBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4BELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LIBERTY PHARMACEUTICALS, INC.]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [LEGACY PHARMACEUTICAL PACKAGING]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJBELLADONNA ALKALOIDS WITH PHENOBARTBITAL TABLET [REBEL DISTRIBUTORS CORP]1

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine HBr 0.0065 MG Oral TabletPSN04bcee32-714d-4f7c-866d-7872b08086901
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine HBr 0.0065 MG Oral TabletPSN316cecca-3357-4589-b980-2b1098e4b47c1
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / PHENobarbital 16.2 MG / scopolamine HBr 0.0065 MG Oral TabletPSN4fd31b5f-afbd-430b-9da2-b2780b3985a61
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral TabletSCD04bcee32-714d-4f7c-866d-7872b08086901
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral TabletSCD316cecca-3357-4589-b980-2b1098e4b47c1
1046815atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral TabletSCD4fd31b5f-afbd-430b-9da2-b2780b3985a61